VenusA-Valve
Commercial- Indications
- Aortic valve disease
Company intelligence / Profile preview
Venus Medtech
Hangzhou, Zhejiang, Chinavenusmedtech.com ↗
- Ownership
- Public · 2500.HK
- Development stage
- Commercial
01
Overview
Venus Medtech develops and commercializes innovative medical devices for the treatment of structural heart diseases. The company has successfully brought products to market in China and internationally; specific clinical results are not detailed in the provided sources but commercialization status indicates successful regulatory approvals.
- Therapeutic areas
- Cardiovascular
- Modalities
- Devicespecifically transcatheter heart valve devices and related structural heart disease technologies
- Industry
- Implantable Medical Devices
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Venus Medtech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Venus Medtech.